chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity, Photopsia
Clinical narrative: second dose which was scheduled for 14May2021 and so the patient did not take it yet.; flash of light in her right eye; temporary blindness followed by blurred vision and double vision in both eyes; dizziness; headache; "COVID arm"; arm had a bumpy rash on it and it was a little bit itchy.; rash spread up to her upper right arm.; fatigue; slightly sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (slightly sore arm), VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.), RASH PAPULAR (rash spread up to her upper right arm.) and DIZZINESS (dizziness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (slightly sore arm). On 21-Apr-2021, the patient experienced FATIGUE (fatigue). On 28-Apr-2021, the patient experienced VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.) and RASH PAPULAR (rash spread up to her upper right arm.). On 03-May-2021, the patient experienced DIZZINESS (dizziness) and HEADACHE (headache). On 06-May-2021, the patient experienced PHOTOPSIA (flash of light in her right eye) and VISION BLURRED (temporary blindness followed by blurred vision and double vision in both eyes). On 14-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose which was scheduled for 14May2021 and so the patient did not take it yet.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 16-Apr-2021, PAIN IN EXTREMITY (slightly sore arm) outcome was unknown. On 21-Apr-2021, FATIGUE (fatigue) had resolved. On 02-May-2021, VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.) and RASH PAPULAR (rash spread up to her upper right arm.) had resolved. On 12-May-2021, DIZZINESS (dizziness), PHOTOPSIA (flash of light in her right eye), VISION BLURRED (temporary blindness followed by blurred vision and double vision in both eyes) and HEADACHE (headache) had resolved. On 14-May-2021, PRODUCT DOSE OMISSION ISSUE (second dose which was scheduled for 14May2021 and so the patient did not take it yet.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       List of concomitant medication were not given.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up information received and contains no new information.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Rash papular, Rash pruritic, Vaccination complication, Vision blurred
Clinical narrative: second dose which was scheduled for 14May2021 and so the patient did not take it yet.; flash of light in her right eye; temporary blindness followed by blurred vision and double vision in both eyes; dizziness; headache; "COVID arm"; arm had a bumpy rash on it and it was a little bit itchy.; rash spread up to her upper right arm.; fatigue; slightly sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (slightly sore arm), VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.), RASH PAPULAR (rash spread up to her upper right arm.) and DIZZINESS (dizziness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (slightly sore arm). On 21-Apr-2021, the patient experienced FATIGUE (fatigue). On 28-Apr-2021, the patient experienced VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.) and RASH PAPULAR (rash spread up to her upper right arm.). On 03-May-2021, the patient experienced DIZZINESS (dizziness) and HEADACHE (headache). On 06-May-2021, the patient experienced PHOTOPSIA (flash of light in her right eye) and VISION BLURRED (temporary blindness followed by blurred vision and double vision in both eyes). On 14-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose which was scheduled for 14May2021 and so the patient did not take it yet.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 16-Apr-2021, PAIN IN EXTREMITY (slightly sore arm) outcome was unknown. On 21-Apr-2021, FATIGUE (fatigue) had resolved. On 02-May-2021, VACCINATION COMPLICATION ("COVID arm"), RASH PRURITIC (arm had a bumpy rash on it and it was a little bit itchy.) and RASH PAPULAR (rash spread up to her upper right arm.) had resolved. On 12-May-2021, DIZZINESS (dizziness), PHOTOPSIA (flash of light in her right eye), VISION BLURRED (temporary blindness followed by blurred vision and double vision in both eyes) and HEADACHE (headache) had resolved. On 14-May-2021, PRODUCT DOSE OMISSION ISSUE (second dose which was scheduled for 14May2021 and so the patient did not take it yet.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       List of concomitant medication were not given.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up information received and contains no new information.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age, SARS-CoV-2 test
Clinical narrative: 04.24.2021  patient received Moderna first dose and 06.09.2021 - Patient  receive Moderna second dose; 17 years old recieved vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old recieved vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04.24.2021  patient received Moderna first dose and 06.09.2021 - Patient  receive Moderna second dose) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old recieved vaccine). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04.24.2021  patient received Moderna first dose and 06.09.2021 - Patient  receive Moderna second dose). On 24-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old recieved vaccine) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04.24.2021  patient received Moderna first dose and 06.09.2021 - Patient  receive Moderna second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information was provided. Action taken with mRNA-1273 was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow up received contains significant information. The lab data was added , the event was upgraded unknown to recovered and one event is added (Inappropriate schedule of vaccine administered).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Skin exfoliation
Clinical narrative: Right hand (palm, fingers) started peeling the skin off.; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Right hand (palm, fingers) started peeling the skin off.) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The medical history was not provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SKIN EXFOLIATION (Right hand (palm, fingers) started peeling the skin off.). At the time of the report, SKIN EXFOLIATION (Right hand (palm, fingers) started peeling the skin off.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter. Treatment information was not provided
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Psoriasis, Tenderness
Clinical narrative: Psoriasis flare-up; elbows were tender; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-May-2021 and was forwarded to Moderna on 25-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis flare-up) and TENDERNESS (elbows were tender) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milligram. On an unknown date, the patient experienced PSORIASIS (Psoriasis flare-up) and TENDERNESS (elbows were tender). At the time of the report, PSORIASIS (Psoriasis flare-up) and TENDERNESS (elbows were tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Arthritis pain has become worse; Injection site continues to be red; Right Arm feels very Hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Right Arm feels very Hot), ARTHRITIS (Arthritis pain has become worse) and VACCINATION SITE ERYTHEMA (Injection site continues to be red) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy, Diabetic (Patient is diabetic since 1990.) since 1990 and Arthritic pains (Arthritis pain seems to have increased since vaccine.) since 2015. Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN, SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), INSULIN DEGLUDEC (TRESIBA) and INSULIN LISPRO (HUMALOG) for Diabetes, DULOXETINE HCL and FUROSEMIDE for Heart disorder, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Right Arm feels very Hot) and VACCINATION SITE ERYTHEMA (Injection site continues to be red). On 20-Apr-2021, the patient experienced ARTHRITIS (Arthritis pain has become worse). The patient was treated with Physical therapy (Ice) for Vaccination site warmth; Physical therapy (Accupuncture) for Arthritis and Physical therapy (Ice) for Vaccination site erythema. At the time of the report, VACCINATION SITE WARMTH (Right Arm feels very Hot), ARTHRITIS (Arthritis pain has become worse) and VACCINATION SITE ERYTHEMA (Injection site continues to be red) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE WARMTH (Right Arm feels very Hot) and VACCINATION SITE ERYTHEMA (Injection site continues to be red) to be possibly related. No further causality assessment was provided for ARTHRITIS (Arthritis pain has become worse).    The red area on the Injection site is approximately 2 inch in circumference.  Patient used numerous creams/ointments/lotions and acupuncture for arthritic pain and currently patient on pain medication with increased dose for arthritic pain.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Significant follow up received on 09-JUL-2021. Vaccine information, patient demographics, medical history, current conditions, concomitant medications, new adverse events and AE outcome updated. Contact details updated.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 years old received vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received vaccine). On 24-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 years old received vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: SECOND DOSE OF COVID VACCINE KICKED BUTTOCKS AND WAS IN BED FOR 24 HOURS; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of VACCINATION COMPLICATION (SECOND DOSE OF COVID VACCINE KICKED BUTTOCKS AND WAS IN BED FOR 24 HOURS) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis and Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (SECOND DOSE OF COVID VACCINE KICKED BUTTOCKS AND WAS IN BED FOR 24 HOURS). At the time of the report, VACCINATION COMPLICATION (SECOND DOSE OF COVID VACCINE KICKED BUTTOCKS AND WAS IN BED FOR 24 HOURS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Age: 43.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Pain of skin, Pruritus
Clinical narrative: skin felt tender and itchy; skin felt tender and itchy; This spontaneous case was reported by a physician and describes the occurrence of PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for an unknown indication.    No medical history was provided by the reporter.    In 2020, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy). At the time of the report, PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: 3"x5" swollen, red, hot area; 3"x5" swollen, red, hot area; 3"x5" swollen, red, hot area; minor pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (3"x5" swollen, red, hot area), VACCINATION SITE PAIN (minor pain), VACCINATION SITE SWELLING (3"x5" swollen, red, hot area) and VACCINATION SITE ERYTHEMA (3"x5" swollen, red, hot area) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for High cholesterol.    On 16-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (minor pain). On 24-Feb-2021, the patient experienced VACCINATION SITE WARMTH (3"x5" swollen, red, hot area), VACCINATION SITE SWELLING (3"x5" swollen, red, hot area) and VACCINATION SITE ERYTHEMA (3"x5" swollen, red, hot area). On 19-Mar-2021, VACCINATION SITE ERYTHEMA (3"x5" swollen, red, hot area) had resolved. At the time of the report, VACCINATION SITE WARMTH (3"x5" swollen, red, hot area) and VACCINATION SITE SWELLING (3"x5" swollen, red, hot area) had resolved and VACCINATION SITE PAIN (minor pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment Medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up information received on 25-05-2021 contains no new information.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, the patient experienced COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine). On 24-May-2021, COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, SARS-CoV-2 test: positive negative (Positive) Positive. On 24-May-2021, SARS-CoV-2 test: negative negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were reported. No treatment medication details was reported.  Follow-up received on 26JUN-2021 included no new information   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Initial Additional-1: No new information added
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Unknown symptoms after second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unknown symptoms after second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unknown symptoms after second dose). At the time of the report, ADVERSE EVENT (Unknown symptoms after second dose) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events were Not Applicable.    Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Erythema, Peripheral swelling, Skin exfoliation, Tenderness
Clinical narrative: Left hand started peeling off; Feet are swollen; Feet are tender; Standing is not a pleasure; It was red for a bit and now it is pink; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Left hand started peeling off), PERIPHERAL SWELLING (Feet are swollen), TENDERNESS (Feet are tender), DYSSTASIA (Standing is not a pleasure) and ERYTHEMA (It was red for a bit and now it is pink) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (Left hand started peeling off), PERIPHERAL SWELLING (Feet are swollen), TENDERNESS (Feet are tender), DYSSTASIA (Standing is not a pleasure) and ERYTHEMA (It was red for a bit and now it is pink). At the time of the report, SKIN EXFOLIATION (Left hand started peeling off), PERIPHERAL SWELLING (Feet are swollen), TENDERNESS (Feet are tender), DYSSTASIA (Standing is not a pleasure) and ERYTHEMA (It was red for a bit and now it is pink) had not resolved.            No Concomitant Medication was provided. No treatment  was provided.  Patient received first shot on  right arm, after a week later patient's  right hand (palm, fingers) started peeling the skin off.   This case was linked to MOD-2021-163993 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received on 23-Jun-2021, no new information was recorded
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: slight fever 24 hours after; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight fever 24 hours after) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (slight fever 24 hours after). At the time of the report, PYREXIA (slight fever 24 hours after) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on forehead and neck; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on forehead and neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on forehead and neck). At the time of the report, RASH (Rash on forehead and neck) outcome was unknown.            Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: right knee pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (right knee pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ARTHRALGIA (right knee pain). At the time of the report, ARTHRALGIA (right knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: This spontaneous case reported by a patient family member or friend, describes the occurrence of vaccination site reaction (magnet sticks to arm at vaccination site) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; unknown. On an unknown date, patient experienced vaccination site reaction (magnet sticks to arm at vaccination site). At the time of the report, vaccination site reaction (magnet sticks to arm at vaccination site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use and treatment information not provided. Reporter did not allow further contact.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Inappropriate schedule of product administration, Musculoskeletal stiffness, Pyrexia
Clinical narrative: received second dose 34 days after first dose; unable to move neck; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose), MUSCULOSKELETAL STIFFNESS (unable to move neck), CHILLS (chills) and PYREXIA (fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose), MUSCULOSKELETAL STIFFNESS (unable to move neck), CHILLS (chills) and PYREXIA (fever). On 01-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose 34 days after first dose) had resolved. On 03-May-2021, MUSCULOSKELETAL STIFFNESS (unable to move neck) had resolved. At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant and treatment medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 100.5; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.5) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever 100.5). At the time of the report, PYREXIA (Fever 100.5) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Med Info Agent AE Submitted  After 24 of 2nd shot I have a fever of 100.5 Yes, plus I had COVID 3 weeks ago
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: soreness; fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Blood pressure high. Concomitant products included CLORAZEPATE DIPOTASSIUM (CLORAZEPATE) for Anxiety, TRIAMTERENE for Blood pressure high, CHOLESTYRAMINE and COLESTYRAMINE (PREVALITE) for Diarrhea, DESIPRAMINE for Sleeplessness, PROPRANOLOL for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN (soreness) and FATIGUE (fatigue). At the time of the report, PAIN (soreness) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. for mRNA-1273(Moderna COVID-19 Vaccine) (Intramuscular) , the reporter did not provide causality assessment.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: concomitant medications added
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pain, Peripheral swelling, Vaccination site pain
Clinical narrative: swell up 3 inches lower the injection site; heat around the injection site; arm pain; Itching around the injection site; Tiredness; redness; swollen arm; body aches; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), PERIPHERAL SWELLING (swell up 3 inches lower the injection site) and VACCINATION SITE WARMTH (heat around the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included LISINOPRIL for Blood pressure management.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), VACCINATION SITE PAIN (arm pain), VACCINATION SITE PRURITUS (Itching around the injection site) and FATIGUE (Tiredness). On 24-May-2021, the patient experienced PERIPHERAL SWELLING (swell up 3 inches lower the injection site) and VACCINATION SITE WARMTH (heat around the injection site). The patient was treated with IBUPROFEN for Pain, at a dose of 200 mg. At the time of the report, ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), PERIPHERAL SWELLING (swell up 3 inches lower the injection site), VACCINATION SITE WARMTH (heat around the injection site), VACCINATION SITE PAIN (arm pain), VACCINATION SITE PRURITUS (Itching around the injection site) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient started to feel arm pain, redness, swollen, itching all in the injected arm, also she states start feeling some tiredness and body aches. Patient toke some Ibuprofen 200Mg for two days and the pain had an improvement, but on 24May2021 she starts feeling pain again, itchiness and started to swell up again the arm, but about 2 or 3 inches lower than the injection site. Patient stated that feel heat on the read area of her arm, and that she's applying cold paths to relief malaise.   Patient applying cold paths to relief malaise.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: swell up 3 inches lower the injection site; heat around the injection site; arm pain; Itching around the injection site; Tiredness; redness; swollen arm; body aches; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), PERIPHERAL SWELLING (swell up 3 inches lower the injection site) and VACCINATION SITE WARMTH (heat around the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included LISINOPRIL for Blood pressure management.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), VACCINATION SITE PAIN (arm pain), VACCINATION SITE PRURITUS (Itching around the injection site) and FATIGUE (Tiredness). On 24-May-2021, the patient experienced PERIPHERAL SWELLING (swell up 3 inches lower the injection site) and VACCINATION SITE WARMTH (heat around the injection site). The patient was treated with IBUPROFEN for Pain, at a dose of 200 mg. At the time of the report, ERYTHEMA (redness), VACCINATION SITE SWELLING (swollen arm), PAIN (body aches), PERIPHERAL SWELLING (swell up 3 inches lower the injection site), VACCINATION SITE WARMTH (heat around the injection site), VACCINATION SITE PAIN (arm pain), VACCINATION SITE PRURITUS (Itching around the injection site) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient started to feel arm pain, redness, swollen, itching all in the injected arm, also she states start feeling some tiredness and body aches. Patient toke some Ibuprofen 200Mg for two days and the pain had an improvement, but on 24May2021 she starts feeling pain again, itchiness and started to swell up again the arm, but about 2 or 3 inches lower than the injection site. Patient stated that feel heat on the read area of her arm, and that she's applying cold paths to relief malaise.   Patient applying cold paths to relief malaise.
Sex: U
Vaccine: COVID19, UNK
Symptoms: Fatigue, Headache
Clinical narrative: Tiredness; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness) and HEADACHE (Headache). At the time of the report, FATIGUE (Tiredness) outcome was unknown and HEADACHE (Headache) had resolved.            Concomitant medications information was not provided. No treatment information was provided.
Age: 50.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Pain in extremity
Clinical narrative: Pain in hand; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pain in hand) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Psoriasis.    Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for Gastroesophageal reflux disease, CLOBETASOL for Psoriasis, LISINOPRIL, IBUPROFEN and DICLOFENAC for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg every two weeks. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in hand). At the time of the report, PAIN IN EXTREMITY (Pain in hand) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) one of the detainees was taken to the hospital and tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.  No treatment information reported.   This case was linked to MOD-2021-163872 (E2B Linked Report).; Sender's Comments:  MOD-2021-163872:Same reporter
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccine ADR; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a  and describes the occurrence of VACCINATION COMPLICATION (Vaccine ADR) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccine ADR). At the time of the report, VACCINATION COMPLICATION (Vaccine ADR) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Fatigue, Feeling abnormal, Insomnia
Clinical narrative: Feeling Terrible; 3 inch by 3 inch inflammed rash that is angry red; rash has left her arm yellowish and bluish; very weak and can not get it together; confusion; Can not sleep; losing weight; sore arm, inner and outer elbow area; very tired,complete exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together) and CONFUSIONAL STATE (confusion) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included CLORAZEPATE DIPOTASSIUM (CLORAZEPATE) for Anxiety, PROPRANOLOL for an unknown indication, DESIPRAMINE.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together), CONFUSIONAL STATE (confusion), INSOMNIA (Can not sleep), WEIGHT DECREASED (losing weight), MYALGIA (sore arm, inner and outer elbow area) and FATIGUE (very tired,complete exhaustion). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH STOPPING CREAM) for Itching, at an unspecified dose and frequency; CEFALEXIN (CEPHALEXINE) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together), CONFUSIONAL STATE (confusion), INSOMNIA (Can not sleep), WEIGHT DECREASED (losing weight), MYALGIA (sore arm, inner and outer elbow area) and FATIGUE (very tired,complete exhaustion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient taking Desipramine for Sleep
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rash erythematous, Skin discolouration, Weight decreased
Clinical narrative: Feeling Terrible; 3 inch by 3 inch inflammed rash that is angry red; rash has left her arm yellowish and bluish; very weak and can not get it together; confusion; Can not sleep; losing weight; sore arm, inner and outer elbow area; very tired,complete exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together) and CONFUSIONAL STATE (confusion) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included CLORAZEPATE DIPOTASSIUM (CLORAZEPATE) for Anxiety, PROPRANOLOL for an unknown indication, DESIPRAMINE.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together), CONFUSIONAL STATE (confusion), INSOMNIA (Can not sleep), WEIGHT DECREASED (losing weight), MYALGIA (sore arm, inner and outer elbow area) and FATIGUE (very tired,complete exhaustion). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH STOPPING CREAM) for Itching, at an unspecified dose and frequency; CEFALEXIN (CEPHALEXINE) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Feeling Terrible), RASH ERYTHEMATOUS (3 inch by 3 inch inflammed rash that is angry red), SKIN DISCOLORATION (rash has left her arm yellowish and bluish), ASTHENIA (very weak and can not get it together), CONFUSIONAL STATE (confusion), INSOMNIA (Can not sleep), WEIGHT DECREASED (losing weight), MYALGIA (sore arm, inner and outer elbow area) and FATIGUE (very tired,complete exhaustion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient taking Desipramine for Sleep
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: could not sleep on left side; COVID arm; Warm; itchy; Swollen; Red circle patch; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (Swollen) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was reported.  Concomitant products included SPIRONOLACTONE for Acne.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Red circle patch). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) (oral) ongoing since an unknown date at a dose of 10 mg once a day. At the time of the report, SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Red circle patch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medicines include birth control pill